Diabetes Empowerment Scale–Short Form (DES-SF)

1. Abstract

The Diabetes Empowerment Scale–Short Form (DES-SF) is an internationally recognized, psychometrically validated, self-report instrument designed to quantify diabetes-specific psychosocial self-efficacy and patient empowerment. Originating from the foundational 28-item Diabetes Empowerment Scale (DES) developed by Robert M. Anderson and colleagues at the Michigan Diabetes Research and Training Center (MDRTC), the short form was engineered to alleviate respondent burden while preserving structural integrity and diagnostic sensitivity. Comprising 8 carefully curated items rated on a 5-point Likert scale (ranging from 1 = Strongly Disagree to 5 = Strongly Agree), the DES-SF captures the critical psychological facets required for effective self-management: psychosocial coping, goal realization, overcoming self-identified barriers, and proactive mobilization of social and medical support.

Psychometric evaluations across diverse clinical and demographic cohorts demonstrate that the DES-SF possesses robust internal consistency reliability, with Cronbach’s alpha coefficients consistently ranging between 0.84 and 0.89. The scale operates primarily as a unidimensional metric of overall empowerment while reflecting the three underlying domains of the parent instrument: (a) managing psychosocial aspects of diabetes, (b) assessing dissatisfaction and readiness to change, and (c) setting and achieving diabetes-related goals. The instrument displays exceptional convergent validity, demonstrating positive correlations with general self-efficacy, self-care behavioral adherence, and psychological resilience, alongside inverse relationships with diabetes-related emotional distress and depressive symptomology. Longitudinal and intervention trials consistently indicate that DES-SF scores are sensitive to educational and behavioral interventions, demonstrating inverse predictive relationships with glycated hemoglobin (HbA1c) levels over time. As a low-burden, clinically actionable psychometric instrument, the DES-SF serves as an indispensable tool in both academic research and routine clinical practice for evaluating diabetes self-management education and support (DSMES).

2. Keywords

Diabetes Empowerment Scale–Short Form, DES-SF, patient empowerment, psychosocial self-efficacy, diabetes self-management, chronic disease adaptation, health psychology, psychometrics, patient-reported outcome measures, behavioral medicine

3. Authors

The Diabetes Empowerment Scale–Short Form was developed by an interdisciplinary team of behavioral scientists, medical educators, and clinical researchers affiliated with the Michigan Diabetes Research and Training Center (MDRTC) at the University of Michigan Medical School in Ann Arbor, Michigan, USA:

• Robert M. Anderson, EdD — Professor Emeritus of Medical Education, Department of Learning Health Sciences, University of Michigan Medical School. A pioneering theorist in patient empowerment and chronic disease self-management education.
• James T. Fitzgerald, PhD — Professor of Learning Health Sciences, University of Michigan Medical School. Psychometrician specializing in measurement theory, scale construction, and medical education evaluation.
• Larry D. Gruppen, PhD — Professor of Learning Health Sciences, University of Michigan Medical School. Expert in cognitive processes, clinical reasoning, and measurement in health professions.
• Martha M. Funnell, MS, RN, CDCES, FAAN — Research Investigator, Department of Learning Health Sciences, University of Michigan Medical School; Adjunct Lecturer, School of Nursing. Past President of Health Care & Education for the American Diabetes Association and an international authority on empowerment-based diabetes education.
• Melissa S. Oh, MPH — Research Associate and biostatistician at the Michigan Diabetes Research and Training Center, University of Michigan.

Collaborative intellectual roots also trace back to Denise G. Marrero, PhD, who co-authored the parent 28-item Diabetes Empowerment Scale published in 2000.

4. Purpose

The primary clinical and theoretical objective of the Diabetes Empowerment Scale–Short Form (DES-SF) is to provide an efficient, psychometrically sound index of an individual’s perceived capability to address the psychosocial, emotional, and behavioral challenges of living with diabetes mellitus (both Type 1 and Type 2). Historically, conventional diabetes evaluation relied predominantly on medical compliance and regimen adherence metrics, which often framed the patient as a passive recipient of clinical directives. The emergence of the empowerment philosophy in chronic illness management exposed the inadequacy of compliance models, demonstrating that day-to-day diabetes care is self-directed and executed almost entirely by the individual outside formal medical settings.

The development of the short form addressed a pervasive operational challenge in health psychology research and routine clinical ambulatory encounters: respondent fatigue and time constraints. While the original 28-item DES yielded nuanced domain-level data across its three subscales, administering a 28-item instrument alongside broad battery surveys (measuring quality of life, depression, self-care behaviors, and dietary intake) created significant respondent burden. The DES-SF was purposefully designed to distill the essential psychosocial dimensions of empowerment into an 8-item assessment that can be completed within 2 to 3 minutes without sacrificing psychometric reliability or predictive validity.

In clinical practice, the DES-SF is employed to:

• Establish baseline psychosocial readiness and psychological resilience prior to enrolling patients in Diabetes Self-Management Education and Support (DSMES) programs.
• Identify specific psychological deficits, such as difficulties in coping with diabetes-related distress, lack of internal motivation, or reluctance to solicit social support.
• Track longitudinal changes in psychosocial self-efficacy following behavioral, technological, or pharmacological interventions.
• Facilitate personalized, collaborative goal setting during clinical encounters by converting numeric scores into qualitative talking points regarding barriers and emotional adjustment.

In empirical research, the DES-SF functions as a robust patient-reported outcome measure (PROM), enabling investigators to examine mediation and moderation models connecting psychological agency with physiological biomarkers, including glycemic variability, lipid profiles, and cardiovascular risk metrics.

5. Psychological Construct

The core psychological construct evaluated by the DES-SF is diabetes-specific psychosocial self-efficacy, conceptualized broadly as patient empowerment. In the context of chronic disease, empowerment is defined not merely as a passive possession of medical knowledge, but as an active, cognitive-affective process through which individuals gain mastery over their decisions, emotional reactions, and life circumstances relating to their condition. The DES-SF captures the operationalization of empowerment across three interdependent theoretical facets derived from its parent scale:

1. Managing Psychosocial Aspects of Diabetes

Living with diabetes requires ongoing cognitive negotiation with emotional vulnerability, societal stigma, fear of microvascular and macrovascular complications, and distress stemming from relentless self-care demands. This dimension examines an individual’s perceived capability to navigate diabetes-related affective disruption. It evaluates whether an individual can recognize stress triggers, deploy constructive coping mechanisms, and maintain emotional equilibrium despite the chronic nature of the condition. For example, items reflecting this construct assess whether the patient can actively find ways to foster positive emotional reframing about living with diabetes (e.g., Item 4) and identify adaptive coping strategies for diabetes-related stress (e.g., Item 5).

2. Assessing Dissatisfaction and Readiness to Change

Grounded in dynamic models of behavioral change, this component evaluates self-awareness regarding the current state of one’s disease management. Effective self-regulation requires realistic metacognitive self-appraisal: an individual must possess the insight to identify which aspects of their daily regimen are generating friction, failure, or dissatisfaction (e.g., Item 1). This cognitive awareness forms the psychological prerequisite for transition from contemplation to deliberate action. Empowerment demands that the patient recognizes personal agency in evaluating what is not working and perceives themselves as capable of initiating behavioral modifications.

3. Setting and Achieving Goals

Empowerment manifests behaviorally through self-directed action planning, problem-solving, and barrier management. This dimension quantifies an individual’s confidence in translating abstract therapeutic objectives (such as optimizing postprandial glucose levels or modifying physical activity) into pragmatic, realistic, and workable behavioral pathways (e.g., Item 2). Furthermore, it evaluates cognitive flexibility—the belief in one’s capacity to experiment with alternative strategies when confronted with environmental, biological, or emotional obstacles (e.g., Item 3). Finally, it encompasses social competence: the perceived ability to mobilize interpersonal and healthcare resources by requesting appropriate support when needed (e.g., Item 6), sustained by intrinsic motivational self-knowledge (Item 7) and self-congruent decision-making (Item 8).

6. Theoretical Framework

The Diabetes Empowerment Scale–Short Form is rooted in the convergence of three foundational psychological paradigms: Albert Bandura’s Social Cognitive Theory, Edward Deci and Richard Ryan’s Self-Determination Theory, and the Patient Empowerment Philosophy articulated by Robert Anderson and Martha Funnell.

Bandura’s Social Cognitive Theory and Self-Efficacy

The foundational bedrock of the DES-SF is Albert Bandura’s construct of self-efficacy, defined as an individual’s subjective conviction in their capability to organize and execute courses of action required to manage prospective situations. Bandura posited that self-efficacy beliefs dictate how much effort people will expend, how long they will persist in the face of obstacles, and how resilient they remain under adverse conditions. In the DES-SF, self-efficacy is explicitly domain-specific: rather than measuring generalized self-efficacy, it appraises self-efficacy beliefs within the complex behavioral and emotional landscape of diabetes. The scale measures cognitive self-appraisals regarding barrier removal, emotional regulation, and self-advocacy.

Self-Determination Theory (SDT)

Under Self-Determination Theory, human motivation thrives when three basic psychological needs are satisfied: autonomy (experiencing oneself as the author and locus of initiation of one’s behaviors), competence (feeling effective in interacting with the environment), and relatedness (feeling connected to and supported by others). The DES-SF directly reflects these tenets:

• Autonomy: Illustrated by the belief that one can make self-directed diabetes care choices tailored to one’s unique identity (Item 8) and acknowledge personal areas of dissatisfaction (Item 1).
• Competence: Operationalized through goal setting, barrier mitigation, and adaptive stress coping (Items 2, 3, 4, and 5).
• Relatedness: Captured by the perceived capability to seek collaborative support without feeling helpless or dependent (Item 6).

The Empowerment Philosophy in Chronic Illness

Developed specifically within diabetes education by Anderson and Funnell, the Empowerment Philosophy fundamentally disputes the conventional acute-care biomedical model. In acute illness, the healthcare provider acts as the expert decision-maker, and the patient complies. In chronic illness, however, the patient makes virtually all self-care decisions that dictate clinical outcomes. Anderson and Funnell argued that true education does not consist of behavioral conditioning or psychological coercion; instead, it consists of cultivating the internal capacity to make informed, self-directed choices. The DES-SF operationalizes this transformation from passive medical obedience to active psychological ownership.

7. Validity

The psychometric validity of the DES-SF has been established across diverse populations, socioeconomic strata, and international translations, confirming that it accurately captures the multidimensional space of psychosocial empowerment.

Construct and Criterion Validity

During the primary validation of the short form by Anderson et al. (2003), construct validity was established by administering the full 28-item DES and extracting candidate short-form items based on factor loadings and content representation. Scores on the resultant 8-item DES-SF demonstrated a near-perfect correlation with overall scores on the 28-item parent scale (r = 0.80 to 0.84, p < 0.001), indicating that the short form successfully preserves the overarching construct integrity of the original instrument without structural degradation.

Convergent Validity

Convergent validity has been repeatedly demonstrated against related psychological constructs and behavioral inventories:

• General Self-Efficacy: DES-SF scores exhibit moderate to strong positive correlations with the General Self-Efficacy Scale (GSE; r = 0.45 to 0.62), demonstrating theoretical convergence while confirming domain-specific distinctiveness.
• Self-Care Behaviors: Positive, statistically significant correlations are consistently identified between the DES-SF and the Summary of Diabetes Self-Care Activities (SDSCA) measure across blood glucose self-monitoring, physical activity, dietary adherence, and foot care (r values typically ranging from 0.28 to 0.48, p < 0.01).
• Health Literacy and Knowledge: Significant positive associations exist between empowerment scores and validated health literacy measures, reflecting the role of comprehensible clinical information in fostering personal agency.

Discriminant Validity

Discriminant validity is supported by robust inverse associations with measures of psychological maladjustment:

• Diabetes-Specific Distress: Scores on the DES-SF inversely correlate with the Problem Areas in Diabetes (PAID) scale (r = -0.38 to -0.54) and the Diabetes Distress Scale (DDS; r = -0.42 to -0.58). Patients who express high empowerment report significantly lower emotional burden, regimen-related distress, and physician-related frustration.
• Depression: Statistically significant negative correlations are documented with general depressive screeners, such as the Patient Health Questionnaire-9 (PHQ-9; r = -0.30 to -0.45) and the Center for Epidemiologic Studies Depression Scale (CES-D).

Predictive and Clinical Validity

Numerous longitudinal and interventional investigations have verified that higher DES-SF scores predict better physiological outcomes. Meta-analytic and multi-center evaluations demonstrate that baseline DES-SF scores or post-intervention increases in DES-SF scores correlate significantly with decreases in glycated hemoglobin (HbA1c). In educational intervention trials, an increase of 1 standard deviation on the DES-SF has been associated with an average HbA1c reduction ranging from 0.4% to 0.8% (4 to 9 mmol/mol) at 3- to 6-month follow-up, confirming the clinical utility of measuring empowerment.

8. Reliability

The DES-SF exhibits outstanding reliability indices across both initial validation cohorts and subsequent global cross-cultural adaptations.

Internal Consistency Reliability

In the seminal development paper by Anderson et al. (2003), which evaluated 228 patients with diabetes participating in community-based educational initiatives, the DES-SF demonstrated a standardized Cronbach’s alpha of 0.84. Given that the instrument contains only 8 items, an alpha value exceeding 0.80 reflects exceptional internal consistency without redundancy. International validation studies have verified comparable internal consistency parameters:

• Swedish version: Cronbach’s α = 0.81 to 0.88.
• Chinese (Mandarin/Cantonese) versions: Cronbach’s α = 0.85 to 0.91 across mainland China, Hong Kong, and Taiwan.
• Korean version: Cronbach’s α = 0.89.
• Spanish and Latin American adaptations: Cronbach’s α = 0.83 to 0.87.
• Turkish adaptation: Cronbach’s α = 0.86.

Item-Total Correlations and Precision

Corrected item-total correlations across the 8 items reliably range between 0.48 and 0.74, well above the recommended psychometric threshold of 0.30. No single item deletion leads to an increase in overall scale alpha, demonstrating that each item contributes uniquely and meaningfully to the total empowerment index. The Standard Error of Measurement (SEM) remains low across diverse cohorts, confirming high measurement precision across both low and high scoring ranges.

Test-Retest Stability

Evaluations of temporal stability among stable, non-intervened clinical cohorts using intraclass correlation coefficients (ICC) over a 2- to 4-week interval demonstrate strong test-retest reliability, with ICC values spanning from 0.76 to 0.89. This high stability ensures that alterations in DES-SF scores captured post-intervention reflect genuine psychological change rather than random measurement fluctuation.

9. Factor Analysis

The structural dimensionality of the DES-SF has been rigorously investigated using both Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA).

Exploratory Factor Analysis (EFA)

In the original developmental analyses conducted by Anderson and colleagues, principal component analysis (PCA) with unrotated and orthogonal (Varimax) rotations was performed. In the parent 28-item instrument, PCA clearly resolved into three distinct factors explaining significant common variance: Factor 1 (Managing Psychosocial Aspects, 9 items, α = 0.93), Factor 2 (Assessing Dissatisfaction and Readiness to Change, 9 items, α = 0.81), and Factor 3 (Setting and Achieving Goals, 10 items, α = 0.91).

When the 8-item short form was constructed, items with the highest factor loadings, clinical relevance, and semantic representation were retained. When subjected to EFA, the DES-SF predominantly converges onto a robust single-factor solution (unidimensional structure). The single dominant factor typically explains between 48% and 62% of the total variance across diverse demographic cohorts, with an initial eigenvalue frequently exceeding 4.0, while secondary eigenvalues fall decisively below 1.0 (scree plot elbow clearly emerging after Factor 1).

Confirmatory Factor Analysis (CFA)

Modern psychometric validations utilizing structural equation modeling (SEM) and CFA have tested both single-factor unidimensional models and second-order hierarchical models (where three first-order factors load onto a general empowerment construct). Results widely endorse the single-factor specification as the most parsimonious and clinically valid representation for total score calculation.

Standardized factor loadings (λ) for all 8 items are uniformly high and statistically significant (p < 0.001), generally ranging from 0.55 to 0.82:

• Item 1 (Dissatisfaction awareness): λ ≈ 0.55 – 0.68
• Item 2 (Workable plan formation): λ ≈ 0.72 – 0.81
• Item 3 (Overcoming barriers): λ ≈ 0.70 – 0.82
• Item 4 (Positive emotional reframing): λ ≈ 0.68 – 0.77
• Item 5 (Stress coping strategies): λ ≈ 0.71 – 0.80
• Item 6 (Mobilizing social support): λ ≈ 0.60 – 0.73
• Item 7 (Motivational insight): λ ≈ 0.73 – 0.82
• Item 8 (Self-congruent decision-making): λ ≈ 0.65 – 0.78

CFA model fit indices for the single-factor model across published validation literature indicate excellent fit:

• Comparative Fit Index (CFI): 0.94 to 0.99 (standard benchmark ≥ 0.95)
• Tucker-Lewis Index (TLI): 0.93 to 0.98 (standard benchmark ≥ 0.95)
• Root Mean Square Error of Approximation (RMSEA): 0.041 to 0.068 (90% CI spanning 0.02 to 0.08)
• Standardized Root Mean Square Residual (SRMR): 0.030 to 0.048 (benchmark ≤ 0.08)

These indices confirm that computing a single composite empowerment score is psychometrically sound and conceptually coherent.

10. Instrument / Measurement Tool

• Instrument Name: Diabetes Empowerment Scale–Short Form (DES-SF)
• Instrument Type: Self-administered, patient-reported outcome measure (PROM) / Psychosocial self-efficacy questionnaire
• Target Population: Adults (aged 18 and older) diagnosed with Type 1 or Type 2 diabetes mellitus. (Validated adolescent versions also exist in specialized literature).
• Administration Format: Paper-and-pencil, computer-assisted web interview (CAWI), or clinical mobile application.
• Completion Time: Approximately 2 to 3 minutes.
• Item Count: 8 items.
• Stem Statement: “In general, I believe that I:”
• Response Format: 5-point Likert scale:
  • 1 = Strongly Disagree
  • 2 = Somewhat Disagree
  • 3 = Neutral
  • 4 = Somewhat Agree
  • 5 = Strongly Agree
• Scoring Algorithm:
  • All items are framed positively; there are no reverse-scored items.
  • Mean Score Calculation: Sum the numerical values of all answered items (ranging from 8 to 40) and divide by the total number of completed items (usually 8). This yields an overall empowerment score ranging from 1.0 to 5.0.
  • Handling Missing Data: If a respondent completes at least 6 of the 8 items (≥ 75%), the mean score of the completed items may be imputed for missing values, or the mean score can simply be calculated by dividing by the number of valid answered items. If more than 2 items are missing, the scale score should generally be regarded as invalid.
• Score Interpretation Guidelines:
  • 1.0 – 2.9: Low Diabetes Empowerment. Indicates significant psychological vulnerability, low perceived self-efficacy, potential diabetes-related distress, and profound difficulties in managing regimens or coping with barriers. Clinical intervention should prioritize supportive counseling, addressing diabetes distress, and simple, highly achievable behavioral goals.
  • 3.0 – 3.9: Moderate Diabetes Empowerment. Reflects neutral to emerging self-efficacy. The individual possesses foundational awareness of diabetes challenges but may struggle when facing complex environmental barriers or emotional setbacks.
  • 4.0 – 5.0: High Diabetes Empowerment. Denotes robust psychosocial agency, well-developed coping and goal-execution strategies, clear self-awareness, and proactive utilization of support mechanisms.

11. Permissions & Fee and Test Year

• Year of Primary Publication: The parent 28-item Diabetes Empowerment Scale was published in 2000. The short form (DES-SF) was formally established and published in 2003.
• Copyright & Intellectual Property: Copyright © 2003 by the University of Michigan, Michigan Diabetes Research and Training Center (MDRTC), Ann Arbor, MI. Authors: Robert M. Anderson, James T. Fitzgerald, Larry D. Gruppen, Martha M. Funnell, and Melissa S. Oh.
• Access and Licensing Policy: The DES-SF is made widely available to the international scientific and clinical community as an open-access, fee-free instrument for non-commercial research and non-profit clinical care.
• Permitted Uses: Researchers, clinical practitioners, certified diabetes educators, and health systems are permitted to utilize the instrument in observational studies, clinical trials, quality improvement initiatives, and routine clinical encounters without paying royalty fees.
• Conditions of Use: The scale items must not be altered or distorted, appropriate intellectual credit must be cited in publications, and the instrument cannot be integrated into commercial software platforms or sold for profit without explicit institutional permissions.
• Repository Information: The official instrument, parent versions, scoring instructions, and authorized non-English translations are archived by the Michigan Diabetes Research Center (MDRC): https://diabetesresearch.med.umich.edu/tools-survey-instruments/.

12. References

Anderson, R. M., Fitzgerald, J. T., Gruppen, L. D., Funnell, M. M., & Oh, M. S. (2003). The Diabetes Empowerment Scale-Short Form (DES-SF). Diabetes Care, 26(5), 1641–1642. https://doi.org/10.2337/diacare.26.5.1641-a

Anderson, R. M., Funnell, M. M., Butler, P. M., Arnold, M. S., Fitzgerald, J. T., & Feste, C. C. (1995). Patient empowerment: Results of a randomized controlled trial. Diabetes Care, 18(7), 943–949. https://doi.org/10.2337/diacare.18.7.943

Anderson, R. M., Funnell, M. M., Fitzgerald, J. T., & Marrero, D. G. (2000). The Diabetes Empowerment Scale: A measure of psychosocial self-efficacy. Diabetes Care, 23(6), 739–743. https://doi.org/10.2337/diacare.23.6.739

Bandura, A. (1997). Self-efficacy: The exercise of control. W. H. Freeman and Company.

Deci, E. L., & Ryan, R. M. (2000). The “what” and “why” of goal pursuits: Human needs and the self-determination of behavior. Psychological Inquiry, 11(4), 227–268. https://doi.org/10.1207/S15327965PLI1104_01

Funnell, M. M., Anderson, R. M., Arnold, M. S., Barr, P. A., Donnelly, M., Johnson, P. D., Tang, T. S., & White, N. H. (1991). Empowerment: An idea whose time has come in diabetes education. The Diabetes Educator, 17(1), 37–41. https://doi.org/10.1177/014572179101700108

Hernandez-Tejada, M. A., Campbell, J. A., Walker, R. J., Smalls, B. L., Davis, K. S., & Egede, L. E. (2012). Diabetes empowerment, medication adherence and self-care behaviors in adults with type 2 diabetes. Diabetes Technology & Therapeutics, 14(7), 630–634. https://doi.org/10.1089/dia.2011.0287

Schinckus, L., Dangoisse, F., Van den Broucke, S., & Mikolajczak, M. (2014). Illness perceptions and diabetes self-management: The mediate role of diabetes empowerment. Health Psychology, 33(8), 834–843. https://doi.org/10.1037/hea0000064

Simmons, C. A., & Lehmann, P. (Eds.). (2013). Tools for strengths-based assessment and evaluation. Springer Publishing Company. https://doi.org/10.1891/9780826199119

Toobert, D. J., Hampson, S. E., & Glasgow, R. E. (2000). The Summary of Diabetes Self-Care Activities measure: Results from 7 studies and a revised scale. Diabetes Care, 23(7), 943–950. https://doi.org/10.2337/diacare.23.7.943

13. Items of the Scale